Japan's Takeda, U.S. Xoma to expand partnership
Tue Feb 10, 2009 2:21am EST
TOKYO, Feb 10 (Reuters) - Takeda Pharmaceutical Co (4502.T: Quote, Profile, Research, Stock Buzz), Japan's largest drugmaker, and U.S. firm Xoma Ltd (XOMA.O: Quote, Profile, Research, Stock Buzz) said on Tuesday they would expand their partnership to give Takeda access to Xoma's multiple antibody technologies.
Takeda and Xoma, which started their collaboration in 2006, said in a joint statement that Takeda would pay a $29 million expansion fee to Xoma as well as potential milestones and royalties on antibody products.
The fees include an estimated $7.5 million in taxes and other costs Xoma may have to shoulder related to the expanded partnership, they said. (Reporting by Yumiko Nishitani) |
